Octagon Capital Advisors’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,364,400
Closed -$9.29M 49
2024
Q2
$9.29M Buy
1,364,400
+739,400
+118% +$5.04M 1.46% 17
2024
Q1
$4.1M Buy
+625,000
New +$4.1M 0.49% 39